|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.05 CAD | -.--% |
|
-.--% | +11.11% |
Xtacy Therapeutics Corp. reported earnings results for the first quarter ended December 31, 2023. For the first quarter, the company reported net loss was CAD 0.265843 million compared to CAD 0.152597 million a year ago.
Basic loss per share from continuing operations was CAD 0.01. Diluted loss per share from continuing operations was CAD 0.01.
| 1st Jan change | Capi. | |
|---|---|---|
| +11.11% | 1.99M | |
| -7.04% | 112B | |
| -7.01% | 84.95B | |
| +16.30% | 61.67B | |
| +3.89% | 60.84B | |
| +8.53% | 42.24B | |
| +8.41% | 41.01B | |
| +17.93% | 34.74B | |
| +1.75% | 24.47B | |
| -6.42% | 21.86B |
XTACY THERAPEUTICS CORP. 
